Table I.
Clinicopathological characteristics of the patients with cervical cancer.
| Expression of CD24 protein Factor | Value | Reduced (%) | Preserved (%) | P-value |
|---|---|---|---|---|
| No. of patients | 117 | 91 (77.8) | 26 (22.2) | |
| Mean age (years) | 51.0±11.5 | |||
| Stage classification | ||||
| Ib | 89 (76.1) | 76 (83.5) | 13 (50.0) | |
| II | 28 (23.9) | 15 (16.5) | 13 (50.0) | <0.01 |
| Histological type | ||||
| Squamous cell carcinoma | 76 (68.1) | 61 (67.0) | 15 (57.7) | |
| Adenocarcinoma | 41 (31.9) | 30 (33.0) | 11 (42.3) | 0.5 |
| Lymph node metastasis | ||||
| Negative | 95 (81.2) | 78 (85.7) | 17 (65.4) | |
| Positive | 22 (18.8) | 13 (14.3) | 9 (34.6) | 0.03 |
| Lymphovascular involvement | ||||
| Negative | 79 (67.5) | 70 (79.6) | 9 (34.6) | |
| Positive | 38 (32.5) | 21 (20.4) | 17 (65.4) | <0.01 |
| Recurrence | ||||
| Negative | 98 (83.8) | 81 (89.0) | 17 (65.5) | |
| Positive | 19 (16.2) | 10 (11.0) | 9 (34.6) | <0.01 |
| Mean follow-up (months) | 41.5±27.3 | |||